Locations:
Abu Dhabi|Canada|Florida|London|Nevada|Ohio|
Gray gradientGray gradient
Cleveland Clinic icon
Consult QD logo

Cancer

19-NEU-6015_CQD_650x450_1

Low-Dose Chemotherapy Reduces Myeloid-Derived Suppressor Cells in Glioblastoma

Capecitabine-based approach shows promise in a population with few options

18-CCC-5885-DNA-PTA-test-650×450
January 15, 2020/Cancer/Research

New Clinic Tackles Mutations That Increase Risk of Blood Cancers and Heart Disease

CHIP Clinic's goals: Research, preventive care

Prostate cancer cells
January 13, 2020/Cancer

Metacure Trial: Can We Cure More Oligometastatic Prostate Cancer?

Study combines hormonal therapy with prostatectomy and radiation therapy of bone lesions

glioma resection using Myriad NOVUS
January 7, 2020/Cancer

First U.S. Clinical Use of Next-Generation Device Brings New Light to Brain Resections

Cleveland Clinic surgeons remove first brain tumor with Myriad NOVUS tool

Advertisement

Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy

Prostate SAbR 650×450
December 27, 2019/Cancer/Radiation Oncology

Testing the Ability to Preserve Erectile Function While Using Stereotactic Ablative Body Radiotherapy for Localized Prostate Cancer

Clinical trial investigates nerve-sparing approach

650×450-invasive-lobular-breast-cancer
December 12, 2019/Cancer/Research

No Survival Advantage from Chemo-endocrine Therapy over Endocrine Therapy in Invasive Lobular Carcinoma

Study suggests limited role for CET in this cancer type

giant platelets
December 11, 2019/Cancer

An Improbable Aortic Surgery in the Setting of Giant Platelet Disorder

Multidisciplinary collaboration enables first such operation in a patient with MYH9 mutation

QD-Follicular-Lymphoma-WINTER
December 9, 2019/Cancer/Research

Lenalidomide/Monoclonal Antibody Combination Superior to PI3K Inhibitor Monotherapy as First Novel Agent in Relapsed Follicular Lymphoma

Study assesses outcomes of therapies with novel agents

T-cells_650x450
December 9, 2019/Cancer/Research

Findings Suggest CAR T-Cell Therapy is Highly Effective for Relapsed/Refractory Mantle Cell Lymphoma

Autologous anti-CD19 agent produces impressive survival improvements

QD-Myelofibrosis-GERDS
December 9, 2019/Cancer/Research

Treatment for Myelofibrosis-Associated Anemia on the Horizon

Interim results of phase 2 trial are promising

BackPage 66 of 91Next

Advertisement

Ad